Compile Data Set for Download or QSAR
Report error Found 85 Enz. Inhib. hit(s) with all data for entry = 50038182
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372815(CHEMBL404893)
Affinity DataIC50: 3.80nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50230534((S)-3-(N-(4-(4-chlorophenoxy)phenyl)methan-15-ylsu...)
Affinity DataIC50: 4.70nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372817(CHEMBL401821)
Affinity DataIC50: 5.5nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372819(CHEMBL404882)
Affinity DataIC50: 6.60nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50230517((S)-N,2-dihydroxy-3-(N-(4-(p-tolyloxy)phenyl)metha...)
Affinity DataIC50: 7.80nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372818(CHEMBL429927)
Affinity DataIC50: 12nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372816(CHEMBL403089)
Affinity DataIC50: 13nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50230529((S)-N,2-dihydroxy-3-(N-(4-(4-(trifluoromethyl)phen...)
Affinity DataIC50: 14nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372817(CHEMBL401821)
Affinity DataIC50: 20nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372812(CHEMBL411519)
Affinity DataIC50: 28nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372820(CHEMBL403169)
Affinity DataIC50: 31nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372797(CHEMBL272763)
Affinity DataIC50: 32nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50230534((S)-3-(N-(4-(4-chlorophenoxy)phenyl)methan-15-ylsu...)
Affinity DataIC50: 35nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372815(CHEMBL404893)
Affinity DataIC50: 36nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372804(CHEMBL270010)
Affinity DataIC50: 39nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372799(CHEMBL403110)
Affinity DataIC50: 44nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372799(CHEMBL403110)
Affinity DataIC50: 47nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372798(CHEMBL272984)
Affinity DataIC50: 47nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372802(CHEMBL408906)
Affinity DataIC50: 54nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372806(CHEMBL258300)
Affinity DataIC50: 54nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372798(CHEMBL272984)
Affinity DataIC50: 56nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50230517((S)-N,2-dihydroxy-3-(N-(4-(p-tolyloxy)phenyl)metha...)
Affinity DataIC50: 61nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372819(CHEMBL404882)
Affinity DataIC50: 61nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372818(CHEMBL429927)
Affinity DataIC50: 67nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372807(CHEMBL270229)
Affinity DataIC50: 69nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372820(CHEMBL403169)
Affinity DataIC50: 73nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372797(CHEMBL272763)
Affinity DataIC50: 91nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372808(CHEMBL270230)
Affinity DataIC50: 93nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372816(CHEMBL403089)
Affinity DataIC50: 102nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372801(CHEMBL429571)
Affinity DataIC50: 104nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372811(CHEMBL270023)
Affinity DataIC50: 124nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50230529((S)-N,2-dihydroxy-3-(N-(4-(4-(trifluoromethyl)phen...)
Affinity DataIC50: 139nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372812(CHEMBL411519)
Affinity DataIC50: 142nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372823(CHEMBL404270)
Affinity DataIC50: 147nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372813(CHEMBL257725)
Affinity DataIC50: 242nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372805(CHEMBL258301)
Affinity DataIC50: 243nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372804(CHEMBL270010)
Affinity DataIC50: 247nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372801(CHEMBL429571)
Affinity DataIC50: 283nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372810(CHEMBL270868)
Affinity DataIC50: 286nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372813(CHEMBL257725)
Affinity DataIC50: 286nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372802(CHEMBL408906)
Affinity DataIC50: 297nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372806(CHEMBL258300)
Affinity DataIC50: 344nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372809(CHEMBL402639)
Affinity DataIC50: 344nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372823(CHEMBL404270)
Affinity DataIC50: 383nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372807(CHEMBL270229)
Affinity DataIC50: 401nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372803(CHEMBL269797)
Affinity DataIC50: 472nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372811(CHEMBL270023)
Affinity DataIC50: 509nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372808(CHEMBL270230)
Affinity DataIC50: 582nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Target72 kDa type IV collagenase(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372822(CHEMBL256018)
Affinity DataIC50: 893nMAssay Description:Inhibition of full length MMP2More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
TargetMatrix metalloproteinase-9(Human)
Johnson & Johnson Pharmaceutical Research and Development

Curated by ChEMBL
LigandPNGBDBM50372814(CHEMBL257724)
Affinity DataIC50: 933nMAssay Description:Inhibition of catalytic domain MMP9More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/15/2012
Entry Details Article
PubMed
Displayed 1 to 50 (of 85 total ) | Next | Last >>
Jump to: